Recently, it has been found that FOXC1 directly activates the transcription of GLI2-mediated SHH targets in human basal-like breast cancer cells by binding and acting as a co-factor to GLI2, bypassing SMO (Han et al. 2015). Here, GLI2 is linked to breast carcinoma.